97 related articles for article (PubMed ID: 2403568)
21. Age-dependent increase of neurotensin expression in the ileum.
Shimoda I; Evers BM; Sato K; Ishizuka J; Rajaraman S; Chung DH; Uchida T; Tsuchiya T; Greeley GH; Townsend CM
Am J Physiol; 1994 Apr; 266(4 Pt 1):G706-12. PubMed ID: 8179005
[TBL] [Abstract][Full Text] [Related]
22. Amphibian neurotensin (NT) is not xenopsin (XP): dual presence of NT-like and XP-like peptides in various amphibia.
Carraway R; Ruane SE; Feurle GE; Taylor S
Endocrinology; 1982 Apr; 110(4):1094-101. PubMed ID: 6977439
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
Muraki K; Mitra SP; Dobner PR; Carraway RE
Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
[TBL] [Abstract][Full Text] [Related]
24. Developmental expression of neurotensin in thyrotropes and gonadotropes of male and female rats.
Bello AR; Reyes R; Hernández G; Negrín I; González M; Tramu G; Alonso R
Neuroendocrinology; 2004 Feb; 79(2):90-9. PubMed ID: 15004431
[TBL] [Abstract][Full Text] [Related]
25. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC
Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030
[TBL] [Abstract][Full Text] [Related]
26. Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: apparent conservation of the COOH-terminal region during evolution.
Carraway R; Ruane SE; Kim HR
Peptides; 1982; 3(2):115-23. PubMed ID: 7099978
[TBL] [Abstract][Full Text] [Related]
27. Biological potency of neurotensin metabolites in vivo: importance of alcohol 'fixation' of blood.
Shulkes A; Fletcher DR; Hardy KJ
J Gastroenterol Hepatol; 1989; 4(5):429-35. PubMed ID: 2491208
[TBL] [Abstract][Full Text] [Related]
28. In vivo inactivation of neurotensin in dog ileum: major involvement of endopeptidase 24-11.
Checler F; Kostolanska B; Fox JA
J Pharmacol Exp Ther; 1988 Mar; 244(3):1040-4. PubMed ID: 2855236
[TBL] [Abstract][Full Text] [Related]
29. Studies on neurotensin. II. Release of neurotensin.
Fujimura M
Nihon Geka Hokan; 1989 Sep; 58(5):414-30. PubMed ID: 2642265
[TBL] [Abstract][Full Text] [Related]
30. Temporal-specific and spatial-specific patterns of neurotensin gene expression in the small bowel.
Evers BM; Ehrenfried JA; Wang X; Townsend CM; Thompson JC
Am J Physiol; 1994 Nov; 267(5 Pt 1):G875-82. PubMed ID: 7977750
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of the neurotensin gene in the developing rat and human gastrointestinal tract.
Evers BM; Rajaraman S; Chung DH; Townsend CM; Wang X; Graves K; Thompson JC
Am J Physiol; 1993 Sep; 265(3 Pt 1):G482-90. PubMed ID: 8214071
[TBL] [Abstract][Full Text] [Related]
32. Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations.
Carraway RE; Mitra SP; Ferris CF
Endocrinology; 1986 Oct; 119(4):1519-26. PubMed ID: 2428598
[TBL] [Abstract][Full Text] [Related]
33. The stability and metabolism of intravenously administered neurotensin in the rat.
Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
[TBL] [Abstract][Full Text] [Related]
34. Characterization of neurotensin(6-13) from an hepatic fibrolamellar carcinoma.
Read D; Shulkes A; Fernley R; Simpson R
Peptides; 1991; 12(4):887-92. PubMed ID: 1664950
[TBL] [Abstract][Full Text] [Related]
35. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
Merchant KM; Hanson GR; Dorsa DM
J Pharmacol Exp Ther; 1994 May; 269(2):806-12. PubMed ID: 8182549
[TBL] [Abstract][Full Text] [Related]
36. On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.
Seebach D; Lukaszuk A; Patora-Komisarska K; Podwysocka D; Gardiner J; Ebert MO; Reubi JC; Cescato R; Waser B; Gmeiner P; Hübner H; Rougeot C
Chem Biodivers; 2011 May; 8(5):711-39. PubMed ID: 21560227
[TBL] [Abstract][Full Text] [Related]
37. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary.
Bagnato A; Moretti C; Ohnishi J; Frajese G; Catt KJ
Endocrinology; 1992 Mar; 130(3):1097-102. PubMed ID: 1537276
[TBL] [Abstract][Full Text] [Related]
38. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
[TBL] [Abstract][Full Text] [Related]
39. Extraction of neurotensin-like immunoreactivities from porcine ileal mucosa.
Yamashita Y; Holst Pedersen J; Stadil F
Peptides; 1987; 8(4):639-43. PubMed ID: 3628080
[TBL] [Abstract][Full Text] [Related]
40. [Endocrine pancreatic tumors].
Lamers CB
Ned Tijdschr Geneeskd; 1982 Apr; 126(17):766-71. PubMed ID: 6285210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
